Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityOther Accumulated ExpensesPayablesReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Marker Therapeutics (MRKR) Treasury Shares (2017 - 2018)

Marker Therapeutics (MRKR) has disclosed Treasury Shares for 2 consecutive years, with $7561.0 as the latest value for Q4 2018.

  • Quarterly Treasury Shares fell 92.26% to $7561.0 in Q4 2018 from the year-ago period, while the trailing twelve-month figure was $7561.0 through Dec 2018, down 92.26% year-over-year, with the annual reading at $7561.0 for FY2018, 92.26% down from the prior year.
  • Treasury Shares for Q4 2018 was $7561.0 at Marker Therapeutics, down from $97639.0 in the prior quarter.
  • The five-year high for Treasury Shares was $97639.0 in Q3 2017, with the low at $7561.0 in Q4 2018.